Lorotox, ear drops 1%+4% 16 g

Otitis

Local symptomatic treatment and analgesia in children from birth and adults for otitis media with intact tympanic membrane, including:

• acute exudative middle otitis;
• otitis as a complication of influenza, exudative viral otitis;
• barotraumatic otitis media.

If necessary, consult a doctor before using the medicine.

Active ingredient

Lidocaine, Phenazone

Composition

1 g of the drug contains:

<

Directions for use

Locally.

Special Instructions

The duration of use of Lorotox® should not exceed 10 days, after which the prescribed treatment should be reviewed.
When using Lorotox® in combination with other ear drops it is necessary to maintain an interval of at least 30 minutes between injections.

Information for athletes: The product contains an active ingredient that may give a positive reaction in doping controls.
Read the instructions carefully before you start using the product. Keep the instructions; you may need them again. If you have any questions, ask your doctor.

Influence on driving and operating ability

The drug does not affect the ability to drive a vehicle or operate complex machinery, machines or any other complex equipment requiring increased attention.

Contraindications

• hypersensitivity to the drug components;
• perforation of the eardrum (including infectious or traumatic origin)
• high sensitivity to pyrazolone derivatives (drugs containing sodium metamizole, phenylbutazone).

Caution

The integrity of the tympanic membrane should be checked before using the drug. If used with a perforated eardrum the product may come into contact with the middle ear and cause complications.

Side effects

There is a risk of local allergic reactions, irritation and hyperemia of the ear canal.

Similarities

Maxicold, Otirelax, Otipax, Maxicold Ototita